Boothbay Fund Management, LLC Kempharm, Inc Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.13 - $6.27 $69,165 - $105,003	16,747 New	16,747 $92,000
Q1 2022 May 16, 2022	SELL	$5.0 - $9.26 $62,580 - $115,898	-12,516 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.6 - $10.26 $3.04 Million - $4.1 Million	-399,900 Reduced 96.97%	12,516 $109,000
Q3 2021 Nov 15, 2021	SELL	$8.72 - $13.31 $252,880 - $385,990	-29,000 Reduced 6.57%	412,416 $3.85 Million
Q2 2021 Aug 16, 2021	BUY	$8.52 - $15.47 $3.76 Million - $6.83 Million	441,416 New	441,416 $5.66 Million

116

26.1M

591K

242K

Ticker KMPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,493,600
Market Cap $170M
Description
KemPharm, Inc., a specialty pharmaceutical company, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds t...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.